Results 211 to 220 of about 3,471,024 (333)
Immuno-metabolic diseases and therapeutics: molecular mechanisms via inflammasome signaling. [PDF]
Cell Commun SignalHan JH.
europepmc +1 more source
SPECIFIC INFLAMMATION OF THE CORNEA IN CHICKENPOX [PDF]
, 1940 A. Loewenstein
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Through a Translational Lens: How Does Inflammation Contribute to the Pathogenesis of Asthma and Allergy? [PDF]
J Inflamm ResKoziol-White CJ, Panettieri RA.
europepmc +1 more source
USE OF THE NITRATE-OF-SILVER OINTMENT IN CHRONIC CONJUNCTIVAL INFLAMMATION, [PDF]
Hugh Neill
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Granulomatous inflammation [PDF]
Revista do Instituto de Medicina Tropical de São Paulo, 1994 Brito, T. de, Franco, M. F.
openaire +5 more sources
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source